Board of Directors | Association for Accessible Medicines
White Paper - Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents

Board of Directors

Company Board Member
3M Health Care Business Silvia Perez
Accord Healthcare Inc. Gerald Price
Alvogen Inc. (Alvogen Group) Lisa Graver
Amneal Pharmaceuticals Chirag Patel
Apotex Corporation Jeff Watson (Board Chair)
Argentum Pharmaceuticals, LLC Jeff Gardner
Aurobindo Pharma US Paul Krauthauser
Baxter Healthcare Corporation Brik Eyre
Cipla USA, Inc. (InvaGen Pharmaceuticals, Inc.) Nikhil Lalwani
Dr. Reddy's Laboratories Inc. Alok Sonig
Fresenius-Kabi USA, LLC John Ducker
G&W Laboratories, Inc. Aaron Greenblatt
Glenmark Pharmaceuticals, Inc., USA Robert Matsuk
Luitpold Pharmaceuticals, Inc. Ken Keller
Lupin Pharmaceuticals, Inc. Paul McGarty
Mayne Pharma Group, Limited  
Momenta Pharmaceuticals, Inc. Craig Wheeler
Mylan, N.V. Heather Bresch
Pfenex Inc. on behalf of The Biosimilars Council Patrick Lucy
Sagent Pharmaceuticals, Inc. (Nichi-Iko Pharmaceuticals Co. Ltd) Dr. Peter Kaemmerer
Sandoz Inc., a Novartis Division Peter Goldschmidt
Sun Pharmaceutical Industries, Inc. (Taro Pharmaceutical Industries Ltd.) Stephen Manzano
Teva Pharmaceuticals USA Andrew Boyer
Virtus Pharmaceutical, LLC Tina Guilder
West-Ward Pharmaceuticals, a Hikma Company Brian Hoffman
Zydus Pharmaceuticals USA Joseph Renner